News
Symbiotec Pharmalab consolidated net profit rises 169.15% in the September 2026 quarter
06-Nov-2026 | 11:39
Sales rise 43.17% to Rs 279.93 crore
Net profit of Symbiotec Pharmalab rose 169.15% to Rs 51.73 crore in the quarter ended September 2026 as against Rs 19.22 crore during the previous quarter ended September 2025. Sales rose 43.17% to Rs 279.93 crore in the quarter ended September 2026 as against Rs 195.52 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 279.93 | 195.52 | 43 |
| OPM % | 32.69 | 25.72 | - |
| PBDT | 85.92 | 44.06 | 95 |
| PBT | 64.04 | 33.47 | 91 |
| NP | 51.73 | 19.22 | 169 |
Powered by Capital Market - Live News